Cramer Won't Buy UnitedHealth Under Probe, But Says Some Think 'The Worst Is Over'
I'm PortAI, I can summarize articles.
Jim Cramer expressed reluctance to buy UnitedHealth Group amid ongoing investigations, although some believe the worst is over. He prefers growth stocks, criticizing AGNC Investment Corp for its lack of growth potential after it reported disappointing earnings. UnitedHealth reaffirmed its 2025 EPS target of at least $16.00, slightly below analyst expectations, while acknowledging the dilutive impact of the Amedisys acquisition. AGNC shares rose 0.1% to $10.35, while UnitedHealth shares increased 8.6% to $347.92.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments